Cargando…

What should we consider in mixed chimerism after hematopoietic stem cell transplantation?

Detalles Bibliográficos
Autor principal:	Lim, Jihyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2011
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128897/ https://www.ncbi.nlm.nih.gov/pubmed/21747889 http://dx.doi.org/10.5045/kjh.2011.46.2.143

Ejemplares similares

Erythema nodosum: what should we consider about it?
por: Babamahmoudi, Farhang, et al.
Publicado: (2016)

Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation
por: Srour, Samer A., et al.
Publicado: (2019)

Systematic comparison of donor chimerism in peripheral blood and bone marrow after hematopoietic stem cell transplantation
por: Bach, C, et al.
Publicado: (2017)

Unusual isolated extramedullary relapse of acute lymphoblastic leukemia in the breast despite complete donor hematopoietic chimerism after allogeneic hematopoietic stem cell transplantation
por: Sung, Pack Hyun, et al.
Publicado: (2018)

COVID 19: Should we consider universal screening in trauma patients?
por: Gopinathan, Nirmal Raj, et al.
Publicado: (2020)

Effective sickle hemoglobin reduction by automated red cell exchange using Spectra Optia in three Emirati patients with sickle cell disease before allogeneic hematopoietic stem cell transplantation
por: Choi, Seung Jun, et al.
Publicado: (2018)

Hematopoietic Stem Cell Transplantation in Refractory Crohn’s Disease: Should It Be Considered?
por: Reider, Simon, et al.
Publicado: (2022)

Multinational monkeypox outbreak: what do we know and what should we do?
por: Memariani, Mojtaba, et al.
Publicado: (2022)

What the neuroradiologist should additionally consider in SARS-CoV-2 infection
por: Finsterer, J., et al.
Publicado: (2020)

Intradialytic hypotension and cardiac remodeling: should we consider the renin-angiotensin-aldosterone system?
por: Wang, Juanli, et al.
Publicado: (2021)

Looking at the day after COVID-19… what laryngeal sequelae should we expect?
por: Torretta, Sara, et al.
Publicado: (2021)

NephroCheck: should we consider urine osmolality?
por: Noto, Alberto, et al.
Publicado: (2019)

Should we consider serum potassium level as a mortality predictor in ST-elevation myocardial infarction?
por: Eyüboğlu, Mehmet
Publicado: (2015)

Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis
por: Abdel-Maboud, Mohamed, et al.
Publicado: (2020)

Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?
por: Stikvoort, Arwen, et al.
Publicado: (2016)

Successful testicular sperm extraction after hematopoietic stem cell transplantation
por: Aworet, Ludmilla Ogouma, et al.
Publicado: (2022)

In reply: efficacy of a new videolaryngoscope; what we should assess?
por: Asai, Takashi, et al.
Publicado: (2012)

Autonomous Sensory Meridian Response: What is It? and Why Should We Care?
por: Lloyd, James V., et al.
Publicado: (2017)

What Should We Do to Help Lessen Older Patients’ Pain?
por: Kim, Sun-Wook
Publicado: (2020)

Prescribing COVID-19 treatments: what we should never forget
por: Tunesi, S., et al.
Publicado: (2020)

Coronavirus Disease 2019 or Lung Cancer: What Should We Treat?
por: Russano, Marco, et al.
Publicado: (2020)

Methodological notes, should be considered in research on mizaj
por: Farahani, Akram Moradi, et al.
Publicado: (2021)

Immune reconstitution profile after allogeneic hematopoietic stem cell transplantation with post-transplant cyclophosphamide
por: Espinoza-Gutarra, Manuel, et al.
Publicado: (2023)

Iron Overload in Hematopoietic Stem Cell Transplantation
por: Yasri, Sora, et al.
Publicado: (2017)

CD4+ T-cell alloreactivity after haploidentical hematopoietic stem cell transplantation
por: Kalin, Burak, et al.
Publicado: (2020)

What All We Should Know About Masks in COVID-19 Pandemic
por: Agrawal, Himanshu, et al.
Publicado: (2020)

Should We Use DSI or not—What does the PADIS 2018 Guidelines Recommend?
por: Sharma, Ankur, et al.
Publicado: (2019)

Covid-19 pandemic and head and neck cancers, what should we expect?
por: Pucci, Resi, et al.
Publicado: (2021)

What should we realistically expect from robotic bronchoscopy in the near future?
por: Ho, Elliot, et al.
Publicado: (2021)

Reply to “Methodological notes, should be considered in research on Mizaj”
por: Aghanouri, Zahra, et al.
Publicado: (2021)

Should statins be considered for the management of mucormycosis in COVID-19?
por: Chatterjee, Subhankar, et al.
Publicado: (2021)

Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’
por: Kow, Chia Siang, et al.
Publicado: (2023)

Bronchoalveolar lavage fluid dilution in ICU patients: what we should know and what we should do
por: Yu, Yuetian, et al.
Publicado: (2019)

Transfusion support in hematopoietic stem cell transplantation
por: Jekarl, Dong Wook, et al.
Publicado: (2023)

Anesthetic concerns in recipients of hematopoietic stem cell transplant
por: Chowdhury, Sumit Roy, et al.
Publicado: (2023)

What We Should Consider for Full Densification when Sintering
por: Kang, Suk-Joong L.
Publicado: (2020)

Immunosuppression in Renal Transplantation and Dyslipidemia, Which Factors Should Be Considered?
por: De Giorgi, Alfredo, et al.
Publicado: (2013)

Pulmonary graft-versus-host disease after autologous hematopoietic stem cell transplantation
por: Choi, Sue In, et al.
Publicado: (2016)

Microbial transglutaminase should be considered as an environmental inducer of celiac disease
por: Lerner, Aaron, et al.
Publicado: (2019)

Should COVID-19 be considered cardiovascular disease risk equivalent?
por: Kow, Chia Siang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l2fbsubcldlmvenjjvm837rugj